PerkinElmer completes $600M purchase of Caliper
In a transaction completed Nov. 7, PerkinElmer purchased Caliper Life Sciences for about $600 million in cash. The Hopkinton, Mass.-based imaging and detection solutions provider will operate within PerkinElmer’s newly formed Life Sciences & Technology Business entity.

PerkinElmer's Chairman and CEO Robert F. Friel said the acquisition will strengthen the company’s position in personalized medicine. Meanwhile, Caliper’s CEO Kevin Hrusovsky will lead a newly formed $500 million business that combines the former Caliper organization with PerkinElmer’s research business, according to Friel.